Full-Time
Posted on 12/10/2025
Healthcare DSP for targeted ads
No salary listed
Pune, Maharashtra, India
Hybrid
DeepIntent operates a demand-side platform tailored to healthcare advertising. It helps healthcare marketers plan, activate, and measure digital ad campaigns across channels to reach both patients and healthcare professionals. The platform uses a proprietary ID graph and an HCP Planner to build precise audiences from trusted data, ensuring ads reach relevant viewers while maintaining privacy and data security in a single, secure environment. This specialization sets DeepIntent apart from general ad tech providers by focusing on healthcare privacy compliance, targeted HCP and patient audiences, and a premium marketplace of brand-safe inventory. The company's goal is to enable effective, privacy-compliant digital campaigns for healthcare clients and demonstrate clear campaign impact through robust measurement and analytics.
Company Size
201-500
Company Stage
Debt Financing
Total Funding
$677M
Headquarters
New York City, New York
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Performance Bonus
SLR Digital Finance (“SLRDF”) provided a $40 million senior secured revolving ABL credit facility to DeepIntent, a leading healthcare advertising demand-side platform (DSP). The facility includes improved terms and an extended maturity through September 2030, providing continued flexibility and support for the Company following a recent investment...
By partnering with DeepIntent, which has specialized compliance infrastructure for healthcare advertising, iHeartMedia can potentially reduce barriers to entry in this lucrative vertical while leveraging its extensive audio reach.
Funding will accelerate DeepIntent’s next phase of growth, product development, and industry leadership – empowering clients with smarter marketing solutions
DeepIntent, a healthcare adtech firm, secured a $637 million investment from Vitruvian Partners, which now holds a majority share. The funding will be used to integrate generative AI tools into DeepIntent's platform. The company will continue to operate independently under CEO Chris Paquette, with a reconstituted board of directors. Vitruvian Partners expressed confidence in DeepIntent's role in personalized healthcare and data-driven advertising.
DeepIntent, a demand-side platform that helps healthcare and pharma brands including AstraZeneca, Bayer, Gilead, and Johnson & Johnson buy ad space, announced Tuesday that it's secured a $637 million investment from private equity firm Vitruvian Partners.